ACE is proud to be investing in SOPHiA GENETICS!

01 October 2020

We are thrilled to be investing in SOPHiA GENETICS, global leader in Data-Driven Medicine!  Today the company announced the closing of a $110 million financing round to enter into the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Data-Driven Medicine worldwide.  To learn more about the investment read the press release here or visit the SOPHiA GENETICS website here!